https://orcid.org/0000-0002-3726-9527
Figures
Abstract
Objective
In Botswana, cervical cancer is the leading cause of cancer death for females. With limited resources, Botswana is challenged to ensure equitable access to advanced cancer care. Botswana’s capital city, Gaborone, houses the only gynecologic oncology multi-disciplinary team (MDT) and the one chemoradiation facility in the country. We aimed to identify areas where fewer women were presenting to the MDT clinic for care.
Methods
This cross-sectional study examined cervical cancer patients presenting to the MDT clinic between January 2015 and March 2020. Patients were geocoded to residential sub-districts to estimate age-standardized presentation rates. Global Moran’s I and Anselin Local Moran’s I tested the null hypothesis that presentation rates occurred randomly in Botswana. Community- and individual-level factors of patients living in sub-districts identified with higher (HH) and lower (LL) clusters of presentation rates were examined using ordinary least squares with a spatial weights matrix and multivariable logistic regression, respectively, with α level 0.05.
Results
We studied 990 patients aged 22–95 (mean: 50.6). Presentation rates were found to be geographically clustered across the country (p = 0.01). Five sub-districts were identified as clusters, two high (HH) sub-district clusters and three low (LL) sub-district clusters (mean presentation rate: 35.5 and 11.3, respectively). Presentation rates decreased with increased travel distance (p = 0.033). Patients residing in LL sub-districts more often reported abnormal vaginal bleeding (aOR: 5.62, 95% CI: 1.31–24.15) compared to patients not residing in LL sub-districts. Patients in HH sub-districts were less likely to be living with HIV (aOR: 0.59; 95% CI: 0.38–0.90) and more likely to present with late-stage cancer (aOR: 1.78; 95%CI: 1.20–2.63) compared to patients not in HH sub-districts.
Conclusions
This study identified geographic clustering of cervical cancer patients presenting for care in Botswana and highlighted sub-districts with disproportionately lower presentation rates. Identified community- and individual level-factors associated with low presentation rates can inform strategies aimed at improving equitable access to cervical cancer care.
Citation: Friebel-Klingner TM, Iyer HS, Ramogola-Masire D, Bazzett-Matabele L, Monare B, Seiphetlheng A, et al. (2022) Evaluating the geographic distribution of cervical cancer patients presenting to a multidisciplinary gynecologic oncology clinic in Gaborone, Botswana. PLoS ONE 17(8): e0271679. https://doi.org/10.1371/journal.pone.0271679
Editor: Sebsibe Tadesse, Wachemo University, ETHIOPIA
Received: July 29, 2021; Accepted: July 5, 2022; Published: August 4, 2022
Copyright: © 2022 Friebel-Klingner et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: Data is not publicly available, because the patients did not consent to have this data shared publicly. A de-identified minimal dataset can be requested with the appropriate IRB approvals for any projects from the corresponding author (Dr. Surbhi Grover) or the Botswana IRB. The Botswana IRB contact person is the Chief Research Officer and their contact phone is +2673632104, or 3632751/2775. The Botswana IRB is the Republic of Botswana Ministry of Health and Wellness Health Research and Development Committee. For questions contact: Mrs. S. Mosweunyane smosweunyane@gov.bw Tel +267-3632754 or Mr. K. Motlhanka kgmmotlhanka@gov.bw tel: 267-3632751.
Funding: Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number F31CA254075 to TFK. Mentored Patient Oriented Career Research Development Award (1-K08CA230170-01A1 to SG) to SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Cervical cancer is a preventable malignancy affecting women worldwide. Mortality from cervical cancer is disproportionately higher in low-resource settings. In 2020, there were an estimated 604,000 new cervical cancer cases and 342,000 deaths, with the vast majority of deaths occurring in low resource settings, predominantly in sub-Saharan Africa (SSA) [1–3]. The majority of cervical cancer deaths in these settings can be attributed to poor access to prevention, screening, and the appropriate treatment [4–7].
In Botswana, an upper-middle-income country in SSA, cervical cancer is the most commonly diagnosed cancer and leading cause of cancer death for females [8]. The population of approximately 2.3 million people currently has over 700,000 women over the age of 20 at risk for developing cervical cancer [9]. The majority of cervical cancers are caused by Human Papilloma Viruses (HPV) [10], and co-infection of HPV and Human Immunodeficiency Virus (HIV) further increases cervical cancer risk [11, 12]. With the third highest HIV burden globally, cervical cancer prevention, screening, and treatment are a national priority in Botswana [13]. In recent decades the Botswana Ministry of Health and Wellness (MOHW) have adapted American Society of Clinical Oncology (ASCO) resource stratified screening strategies for its citizens, with the majority of cervical cancers being detected through loop electrosurgical excision procedure or visual inspection with acetic acid [13].
Botswana’s cancer control program is challenged with limited resources to ensure equitable access to advanced health care. A critical factor that affects cancer outcomes is a delay in a diagnosis resulting in the progression of a malignant tumor [14–16]. Thus, delayed access to care is essential when considering cancer morbidity and mortality. One aspect of access is geographic accessibility. Botswana is a sparsely populated country with only one clinic with a multi-disciplinary team (MDT) for gynecological oncology located in the capital city, Gaborone. The MDT clinic includes Botswana’s only gynecological oncologist and the one chemoradiation facility in the country capable of providing the standard of care, including staging and treatment, for cervical cancer patients diagnosed with locally advanced disease [17, 18].
Gaborone is located in the country’s southeast corner, over 1000 km away from the furthest residential areas. Geography, therefore, may be a significant barrier for accessing care [16]. Geographic information systems (GIS), which enables capturing and analyzing spatial and geographic data from a wide range of sources in conjunction with one another, is an efficient and robust methodical framework to investigate the role of geography and health in a population [19, 20]. The use of GIS technology and methods is rapidly evolving. GIS can help identify areas of limited access and help direct resources/planning efforts and illuminate factors that contribute to the bigger picture of public health. These methods can contribute to the limited cancer information available in low resource settings [21–23]. To our knowledge this is the first study to apply GIS methods to investigate the geographic distribution of cervical cancer patients presenting for care in Botswana.
The World Health Organization’s projected incidence of cervical cancer in Botswana for 2020 calculated using the Botswana National Cancer Registry [8] data from 2004–2008 is 374 cases [24]. Given one comprehensive MDT clinic where all women diagnosed with locally advanced cervical cancer should be referred to for treatment, we would anticipate over 300 cervical cancer cases to be referred to the MDT clinic per year. However, the MDT clinic has averaged less than 200 cases/year for the past five years (range: 96–256). We hypothesized that due to the lack of equitable access, not all women diagnosed with cervical cancer throughout Botswana are presenting to the MDT clinic for staging and treatment and that the rate of patients presenting for treatment is not random throughout Botswana. We applied GIS to identify areas with high or low presentation rates and highlight areas where suboptimal patterns of care exist. Highlighting areas with low presentation rates and understanding community- and individual-level characteristics associated with living in areas with low presentation rates can inform strategies for more equitable distribution of resources and highlight areas needing improved access to cancer treatment facilities.
Materials and methods
Study participants
This cross-sectional study included biopsy-proven cervical cancer patients referred to the MDT clinic between January 2015 and March 2020. The MDT clinic, located within Princess Marina Hospital (PMH), coordinates care for all gynecological oncology patients referred to the two tertiary hospitals in Gaborone: PMH and Gaborone Private Hospital (GPH) [18]. Patients who were over the age of 18, not pregnant, and were not diagnosed with cervical carcinoma in situ or recurrent disease, and had provided written, informed consent were included.
Primary outcome measure
Our primary outcome was the rate of cervical cancer patients presenting to the MDT clinic for staging and/or treatment, henceforth referred to as ‘presentation rate’. To detect areas in Botswana with disproportionately high or low presentation rates, we defined our geographic unit of analysis as administrative sub-districts in Botswana. We used an available shapefile from the USCB [9] that defined the 2nd-order administrative boundaries for 28 sub-districts throughout the country. The USCB also defines 519 3rd order administrative divisions described as “villages and associated localities” [9]. We abstracted each patient’s residential village from the questionnaire and geocoded each patient to one of USCB’s identified 519 villages [9].
To calculate the presentation rates, we aggregated cervical cancer patients per village and identified the appropriate administrative sub-district for each village. The denominator for each sub-district consisted of the total female population for patients 20 years and older from January 2015 to March 2020 [9]. We standardized the presentation rates using the overall Botswana female age distribution. Age-standardized presentation rates by sub-district were visually inspected using choropleth maps created in ArcGIS version 10.6.1 (Esri, Redlands, CA) for geographic variation.
Covariates
Sub-district-level covariates included HIV prevalence, population density, and travel distance to the MDT clinic in Gaborone. The HIV prevalence for each sub-district was obtained from the Botswana AIDS Impact Survey IV [25]. The population density was calculated using the projected population relative to the polygon area per sub-district using projected estimates and the polygon area from the shapefile from the USCB [9]. Travel burden was determined using Google maps [26, 27] calculated as distance in kilometers traveled from the centroid of each sub-district to the MDT clinic in Gaborone.
A questionnaire was administered at the first visit to the MDT clinic. Data collected included patient sociodemographic and clinical factors. Sociodemographic factors included age, marital status, and village of residence; clinical factors included history of cervical cancer screening, ever/never visit with a traditional doctor and/or natural healer, presence of abnormal vaginal bleeding (including post-coital bleeding/bleeding after vaginal intercourse), and HIV status. Additional clinical data was abstracted from medical records for cervical cancer stage at presentation based on the International Federation of Gynecology and Obstetrics (FIGO) staging system [28, 29].
Geographic analysis
To assess geographic patterns of presentation rates both nationally and locally, we employed Global Moran’s I and Anselin local index of spatial autocorrelation statistics, respectively [30, 31]. Global Moran’s I test was conducted to assess if presentation rates across the country were clustered, dispersed, or random (null hypothesis) and Anselin local index was used to investigate patterns of presentation rates for each sub-district [30, 31].
For Global Moran’s I, a positive spatial autocorrelation result indicates clustering, describing sub-districts with similar presentation rates within close geographic proximity to each other. Negative spatial autocorrelation reveals dispersion, noting sub-districts with dissimilar presentation rates were closer in geographical proximity in a manner that was not random. A null result indicates presentation rates across Botswana was random.
For the Global Moran’s I geographic analysis we defined neighbors using queen’s contiguity matrix [32] and conducted permutation tests with 999 simulations for significance. Using this weights matrix, the Global Moran’s I test enables presentation rates of each sub-district to be correlated with the mean presentation rates of neighboring sub-districts (spatial autocorrelation), thereby accounting for spatial dependence in presentation rates between sub-districts.
Next, using Anselin’s local index, we investigated patterns of presentation rates for each sub-district [30, 31]. This approach determines whether each individual (target) sub-district’s presentation rates are uniformly similar or disproportionately high or low relative to the mean presentation rates of that sub-district’s neighbors, once again defined by Queen’s contiguity matrix [32]. Permutation tests with 999 simulations were conducted and statistically significant clusters (similar presentation rates) or outliers (dissimilar presentation rates) were identified with 95% confidence intervals. A significant result revealed one of four possible categories for each sub-district, two types of clusters or two types of outliers. A high-high (HH) cluster indicated target sub-districts with high presentation rates were surrounded by neighboring sub-districts with high presentation rates. Conversely low-low (LL) clusters identified target sub-districts with low presentation rates surrounded by neighboring sub-districts with low presentation rates. High-low (HL) or low-high (LH) outliers indicated an inverse relationship between the target sub-district presentation rates and the mean of their neighbor’s presentation rates.
Statistical analysis
Simple ordinary least squares (OLS) regression investigated the relationship of age-standardized presentation rates across the country with sub-district level community factors. If Moran’s I identified significant autocorrelation, we accounted for non-independence of presentation rates in our multivariable OLS regression model using a spatial weights matrix [33] to investigate associations with sub-district level variables (HIV prevalence, population density, and travel distance).
Lastly, we investigated individual-level clinical and demographic characteristics among cervical cancer cases living in a clustered (HH/LL) or outlier (HL/LH) identified sub-district compared to patients living in any other sub-district. Univariate individual level differences were assessed using student t-tests, chi-squared tests, and fishers exact tests as appropriate. Additionally, multivariable logistic regression models determined the magnitude of associations for patients living in identified LL or HH sub-districts versus patients not living in these sub-districts, while adjusting for demographic and clinical characteristics. Adjusted odds ratios and 95% confidence intervals with a cut-off α value of 0.05 determined significant associations. We performed geospatial analysis in ArcGIS version 10.6.1 (Esri, Redlands, CA) and open source GeoDa software [33]. We conducted all Statistical analysis in STATA 16.1 (College Station, TX).
Ethics approval
The parent study, “Treatment and Outcomes of Patients Presenting with Cancer in Botswana,” was approved at the University of Pennsylvania as part of the Botswana-University of Pennsylvania Partnership (IRB: 820159 IRB#7 Penn) and by the Ministry of Health and Wellness of the Republic of Botswana (HPDME 13/18/1).
Results
One thousand nineteen cervical cancer patients presented to the MDT clinic between January 2015 and March 2020. Nineteen patients (1.8%) diagnosed with cervical carcinoma in situ and 7 (0.7%) patients with recurrent disease were excluded. Thirty-four patients (3.3%) were missing village of residence, but 31 of these did have sub-district of residence and were geocoded to their respective sub-district. Thus, 990 cervical cancer patients were geocoded to one of the 28 sub-districts. Sociodemographic and clinical characteristics are shown in Table 1. Cervical cancer patients had a mean age of 50.6 years at time of presentation (range: 22.4–95.2). The overall presentation rate was 27.2 per 100,000 women (IQR: 12.5–35.0) for our study period. Age-standardized presentation rates by sub-districts are visually presented in a choropleth map (Fig 1). Crude and age-standardized presentation rates are presented in Table 2.
*created in ArcGIS version 10.6.1 (Esri, Redlands, CA).
Positive spatial autocorrelation was observed (Global Moran’s I = 0.249; p = 0.014), identifying positive geographic clustering of cervical cancer rates across the country. Anselin local Moran’s I identified specific sub-districts where presentation rates were disproportionately high or low relative to their neighbors. Of the 28 sub-districts, five significant clustered (17.8%) sub-districts were identified, 2 HH and 3 LL sub-districts (Fig 2). No outliers (HL or LH sub-districts) were found. Two sub-districts were determined as HH clusters: Kgalagadi South and Southern (age-standardized rate per 100,000 women: 29.8 and 41.2, respectively). Three sub-districts were determined as LL clusters: Ngamiland West, Ngamiland East, and Ghanzi (age-standardized rate per 100,000 women: 9.5, 13.8, and 10.6 respectively).
*created in ArcGIS version 10.6.1 (Esri, Redlands, CA).
Community-level factors for HH and LL sub-district clusters are shown in Table 3. HH sub-districts had a mean presentation rate of 35.5 per 100,000 women and LL sub-districts had a mean presentation rate of 11.33 per 100,000 women. Population density was 8.82 per km2 for HH sub-districts and 1.94 km2 for LL sub-districts. For HH sub-distritcs, the mean HIV prevalance for females was from 11.45 per 100,000 women and for LL sub-districts 15.27 per 100,000 women.
Results from OLS regression showed a significant association between presentation rates across Botswana with travel distance (coefficient: -0.020, p = 0.034) to Gaborone, but no association with population density or HIV prevalence. Using the spatial weights matrix, multivariable OLS found that presentation rates across Botswana increased with decreased travel distance to Gaborone (adjusted coefficient: -0.026, p = 0.033). No significant associations were found for HIV prevalence or population density (Table 4).
Univariate individual-level differences for patients living in an LL sub-district were compared to not living in an LL sub-district and for patients living in a HH sub-district were compared to not living in a HH sub-district (Table 5). Women presenting from LL sub-districts were more commonly HIV positive (p = 0.025) and more often reported abnormal vaginal bleeding (p = 0.008) than women not presenting from LL sub-districts. Women presenting from HH sub-districts were older (p = 0.010), more commonly HIV negative (p<0.001), and more often presented with late-stage disease (p = 0.009) compared to women not presenting from HH sub-districts.
Additionally, multivariable logistic regression identified individual level factors associated with patients living in sub-districts with disproportionate presentation rates (Table 6). Patients living in LL sub-districts compared to patients not living in a LL sub-district more often reported experiencing abnormal vaginal bleeding (aOR: 5.88, 95% CI: 1.37–25.23) and were more likely to be HIV positive, though this did not reach statistical significance (aOR: 3.29; 95% CI: 0.97–11.17). These results should be interpreted with caution and considered exploratory due to the limited number of patients presenting from LL sub-districts. Patients living in HH sub-districts were less likely to be living with HIV relative to those not living in HH sub-districts (aOR: 0.46; 95% CI: 0.27–0.78) and more likely to be diagnosed with late-stage cervical cancer (aOR: 1.85; 95%CI: 1.19–2.87) compared to patients not living in a HH sub-district.
Discussion
This study reveals non-random geographic patterns of patients diagnosed with cervical cancer throughout Botswana presenting to the MDT clinic in Gaborone. We identified specific areas of the country with disproportionately high and low presentation rates, indicating that areas with low presentation rates may have poor access to the one comprehensive care MDT clinic in Botswana. The areas with high presentation rates may have better access to the MDT clinic. Patients living in sub-districts with low presentation rates were more likely to present with abnormal vaginal bleeding, and patients living in sub-districts with high presentation rates were more likely to be HIV negative and more likely to present with late-stage disease. Identifying community and individual level factors associated with access to comprehensive cervical cancer care gives national health programs insight when developing strategies that target areas and populations being underserved by health care facilities. These strategies will be vital in preventing and controlling the emerging cervical cancer burden in Botswana.
In the literature, GIS methods have been used to examine local and regional variation of disease and to understand equity of access to care, as significant clustering of diseases may indicate potential inequity in access [34–36]. We carried out this study with the theory that geographic differences in presentation rates does not reflect the incidence or prevalence of cervical cancer but rather differences in patients accessing and presenting for treatment. Co-infection of HIV and HPV increases the risk of cervical cancer [11, 12], but our results identified no association between sub-district-level HIV prevalence and presentation rates across the country. This supports the hypothesis that the presentation rate is not likely a reflection of cervical cancer incidence or prevalence, but rather due inequity of access.
The literature has also reported that access to care is an important factor for cancer survival, particularly in low-resource settings [7, 37, 38]. Penchansky and Thomas [39] reported that access is multi-dimensional and consists of availability, accessibility, accommodation, affordability and acceptability. It could be inferred that sub-districts with high presentation rates have greater access than other sub-districts to care. One dimension of access is accessibility, or travel distance to the health center. Our results found that shorter/greater travel distance to the MDT clinic in Gaborone was associated with higher/lower presentation rates. Sub-districts in the Southern region of Botswana with closer proximity to Gaborone had increased presentation rates. In contrast, sub-districts with low presentation rates were identified in the northwest, furthest away and separated from Gaborone by the Central Kalahari Game Reserve, making travel to Gaborone much more challenging. Our study suggests that travel-distance accessibility to the MDT clinic in Gaborone presents a major barrier to care for cervical cancer patients in specific areas of the country.
Geographic accessibility is one factor impacting access to care. A more detailed understanding of this and other barriers of access in areas with low presentation rates could inform strategies to increase the number of cervical cancer cases presenting for care. Of note, sub-districts with higher presentation rates were not geographically the closest sub-districts to Gaborone, and Gaborone itself was not an area within a high-high cluster, further signifying that additional dimensions of access besides travel-distance accessibility are influencing access to care. For example, another barrier of access is lack of knowledge. Studies have shown that lack of knowledge regarding cervical cancer and cervical cancer screening as an identified barrier for cervical cancer care in Botswana; thus knowledge may differ according to geography [14, 40]. Tapela et. al. demonstrated a successful strategy implemented in Botswana at the healthcare level led to improved knowledge for primary care providers and reduced health system delays [41]. Understanding knowledge gaps in areas with low presentation rates could potentially increase cervical cancer patients presenting for care.
Previous studies in Botswana have shown that the lack of understanding of symptom severity is associated with a delay in seeking care [14, 40]. Patients in sub-districts with low rates often reported abnormal vaginal bleeding, indicating that they may not receive prompt medical attention and are not being referred until later stages when they are symptomatic. It may be beneficial to assess awareness of symptoms in areas with low presentation rates and areas with high presentation rates to understand if there is a difference at the provider or patient level in understanding abnormal vaginal bleeding as a symptom of cervical cancer. These findings also support previous reports to increase awareness, education, and screening for asymptomatic women in order to be able to detect cervical cancer at an earlier stage and improve outcomes [14, 40].
Our study also found that sub-districts with high presentation rates were associated with cervical cancer cases more likely to present at a late stage. While this may seem counterintuitive, due to the lack of comprehensive screening for asymptomatic women, cases throughout the country are more likely to be diagnosed at a late stage. Most studies have found that for SSA, including Botswana, more than half of cervical cancer cases are diagnosed at a late stage [5, 14, 42]. We could hypothesize that for sub-districts with higher access to Gaborone, patients diagnosed at a late stage when symptoms are present and morbidity is increased, may still be able to present to the MDT clinic for staging and treatment. However, with limited accessibility, patients diagnosed at a later stage further away from Gaborone may not be able to travel to the MDT clinic for treatment before succumbing to their illness. Thus, less late-stage cancers would be presenting from areas with low access. While our work does not directly address this inconsistency, future work could investigate the true prevalence of cervical cancer and the influence of morbidity in areas with low access or low rates.
In Botswana, cervical cancer screening and care have been implemented as part of the HIV care continuum [43]; thus, women living with HIV are likely to have increased health visits, more contact with health providers, and increased health literacy. Sub-districts with higher presentation rates had more HIV negative women present for treatment despite having no significant difference in community level HIV prevalence. A previous study also speculated that access to care may be differential according to HIV status in Botswana [44]. Thus, it is plausible that HIV negative women in sub-districts with lower presentation rates may be limited in cervical cancer awareness, screening, and contact with health care services. Increasing health literacy by developing and implementing educational programs, as well as increasing other health services, particularly in areas with low presentation rates and among women without HIV, could educate more women about the risks and symptoms of cervical cancer and the importance of screening and early detection to combat this disease. These efforts may increase the number of cervical cancers detected and increase the number of patients presenting for cervical cancer care.
Our study, the first to apply GIS to assess patterns of cervical cancer patients presenting for treatment in Gaborone, has limitations. It is important to note that due to the cross-sectional study design, no decisive conclusions can be made about the temporality or causality among the individual-level study variables. Also, those not seeking advanced medical care for symptoms of cervical cancer at the MDT clinic would not be captured in this cohort. The potential for selection bias would result in underrepresentation of cervical cancer in our dataset and the degree of selection bias could vary by geography, travel distance and other factors that could have impact on our results. For example, if patients with early-stage disease were being surgically treated for cervical cancer outside of the MDT clinic in areas with low presentation rates, this could bias our results towards the null and reject our hypothesis that less patients are presenting for care from these areas. In addition, community- and individual-level factors, such as poverty, socioeconomic status, education level and employment were not accounted for. These social determinants of health, likely to be geographically dependent, also influence various aspects of access. Future work to investigate these factors could contribute to a better understanding of the barriers of access in sub-districts with low presentation rates. Not accounting for these additional confounding or modifying factors could lead to a misinterpretation of our results. For example, if there is less awareness in areas further away from Gaborone, this lack of knowledge could explain the low presentation rates instead of travel distance. Future work accounting for additional dimensions of access is important to fully understand the barriers in areas with low presentation rates.
Our results reveal areas in Botswana with low presentation rates and where women living with cervical cancer may not be presenting for appropriate cervical cancer care. Our results also hypothesize about community- and individual-level factors that could be limiting access to health care for areas with low presentation rates. Our results indicated travel distance is a potential barrier to accessing cervical cancer care. We also identified that a potential area for intervention to mitigate the cervical cancer burden at the individual level could be to increase efforts for women without HIV, including assessing and improving knowledge in this population related to cervical cancer and cervical cancer screening. This finding is consistent with our previous studies [44, 45] indicating that access to care may be differential according to HIV status in Botswana. Our previous study [45] noted that WLWH were more likely to report having had cervical cancer screening (62% of WLWH reported cervical cancer screening versus 48% of women without HIV). Thus, future efforts to increase awareness campaigns and cervical cancer screening efforts to include women without HIV could be warranted. Additionally, early cervical cancer detection efforts should emphasize cancer symptom awareness, particularly abnormal vaginal bleeding, and educate women about the steps women should take if they experience symptoms.
Conclusion
Botswana carries a heavy burden of cervical cancer. Access to adequate treatment is essential for early diagnosis and increased survival. Improving equitable access to cervical cancer treatment for women living in sub-districts with lower rates of cervical cancer patients presenting for care should be prioritized to help reduce the morbidity and mortality of cervical cancer.
Acknowledgments
We thank Rebecca Ketlametswe, Princess Marina Hospital, Gaborone Private Hospital, the Botswana Ministry of Health, and the Centers for Disease Control and Prevention for their constant support, and all of our patients, who made this study possible.
References
- 1. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pineros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019; 144:1941–53. pmid:30350310
- 2. Arbyn M, Weiderpass E, Bruni L, de Sanjose S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020; 8:e191–e203. pmid:31812369
- 3. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71:209–49. pmid:33538338
- 4. Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ. 2001; 79:954–62. pmid:11693978
- 5. Jemal A, Bray F, Forman D, O’Brien M, Ferlay J, Center M, et al. Cancer burden in Africa and opportunities for prevention. Cancer. 2012; 118:4372–84. pmid:22252462
- 6. Burt LM, McCormak M, Lecuru F, Kanyike DM, Bvochora-Nsingo M, Ndlovu N, et al. Cervix Cancer in Sub-Saharan Africa: An Assessment of Cervical Cancer Management. JCO Glob Oncol. 2021; 7:173–82. pmid:33529076
- 7. Munyaneza F, Ntaganira J, Nyirazinyoye L, Birru E, Nisingizwe MP, Gupta N, et al. Community-Based Accompaniment and the Impact of Distance for HIV Patients Newly Initiated on Antiretroviral Therapy: Early Outcomes and Clinic Visit Adherence in Rural Rwanda. AIDS Behav. 2018; 22:77–85. pmid:28025738
- 8.
Botswana National Cancer Registry. [cited 2019 November 20]; http://afcrn.org/membership/members/118-bncr.
- 9.
Bureau USC. Subnational Population by Sex, Age, and Geographic Area. 2019 [cited 2021]; https://www.census.gov/data/tables/time-series/demo/international-programs/subnationalpopulation.html.
- 10. Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet. 2013; 382:889–99. pmid:23618600
- 11. Liu G, Sharma M, Tan N, Barnabas RV. HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer. AIDS. 2018; 32:795–808. pmid:29369827
- 12. Stelzle D, Tanaka LF, Lee KK, Ibrahim Khalil A, Baussano I, Shah ASV, et al. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2021; 9:e161–e9. pmid:33212031
- 13. Grover S, Raesima M, Bvochora-Nsingo M, Chiyapo SP, Balang D, Tapela N, et al. Cervical Cancer in Botswana: Current State and Future Steps for Screening and Treatment Programs. Front Oncol. 2015; 5:239. pmid:26579491
- 14. Anakwenze C, Bhatia R, Rate W, Bakwenabatsile L, Ngoni K, Rayne S, et al. Factors Related to Advanced Stage of Cancer Presentation in Botswana. J Glob Oncol. 2018; 4:1–9. pmid:30532993
- 15. Brown CA, Suneja G, Tapela N, Mapes A, Pusoentsi M, Mmalane M, et al. Predictors of Timely Access of Oncology Services and Advanced-Stage Cancer in an HIV-Endemic Setting. Oncologist. 2016; 21:731–8. pmid:27053501
- 16. Brown CA, Kohler RE, John O, Motswetla G, Mmalane M, Tapela N, et al. Multilevel Factors Affecting Time to Cancer Diagnosis and Care Quality in Botswana. Oncologist. 2018; 23:1453–60. pmid:30082488
- 17. Seitio-Kgokgwe O, Gauld RD, Hill PC, Barnett P. Assessing performance of Botswana’s public hospital system: the use of the World Health Organization Health System Performance Assessment Framework. Int J Health Policy Manag. 2014; 3:179–89. pmid:25279380
- 18. Grover S, Chiyapo SP, Puri P, Narasimhamurthy M, Gaolebale BE, Tapela N, et al. Multidisciplinary Gynecologic Oncology Clinic in Botswana: A Model for Multidisciplinary Oncology Care in Low- and Middle-Income Settings. J Glob Oncol. 2017; 3:666–70. pmid:29094103
- 19. Nykiforuk CI, Flaman LM. Geographic information systems (GIS) for Health Promotion and Public Health: a review. Health Promot Pract. 2011; 12:63–73. pmid:19546198
- 20. Musa GJ, Chiang PH, Sylk T, Bavley R, Keating W, Lakew B, et al. Use of GIS Mapping as a Public Health Tool-From Cholera to Cancer. Health Serv Insights. 2013; 6:111–6. pmid:25114567
- 21. Schootman M, Gomez SL, Henry KA, Paskett ED, Ellison GL, Oh A, et al. Geospatial Approaches to Cancer Control and Population Sciences. Cancer Epidemiol Biomarkers Prev. 2017; 26:472–5. pmid:28325736
- 22. Boyda DC, Holzman SB, Berman A, Grabowski MK, Chang LW. Geographic Information Systems, spatial analysis, and HIV in Africa: A scoping review. PLoS One. 2019; 14:e0216388. pmid:31050678
- 23. Raykar NP, Bowder AN, Liu C, Vega M, Kim JH, Boye G, et al. Geospatial mapping to estimate timely access to surgical care in nine low-income and middle-income countries. Lancet. 2015; 385 Suppl 2:S16. pmid:26313062
- 24.
IARC. Botswana: Globocan 2020. 2020 [7/29/2021]; https://gco.iarc.fr/today/data/factsheets/populations/72-botswana-fact-sheets.pdf.
- 25.
(NACA) NACA. Botswana AIDS Impact Survey IV. 2013; https://www.statsbots.org.bw/sites/default/files/publications/BOTSWANA%20AIDS%20IMPACT%20SURVEY%20IV%202013.pdf.
- 26.
Google. Botswana, Google Maps. 2021 [cited 2021]; https://www.google.com/maps/place/Botswana.
- 27. Banke-Thomas A, Wong KLM, Collins L, Olaniran A, Balogun M, Wright O, et al. An assessment of geographical access and factors influencing travel time to emergency obstetric care in the urban state of Lagos, Nigeria. Health Policy Plan. 2021; 36:1384–96. pmid:34424314
- 28. Bhatla N, Berek JS, Cuello Fredes M, Denny LA, Grenman S, Karunaratne K, et al. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet. 2019; 145:129–35. pmid:30656645
- 29. Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019; 393:169–82. pmid:30638582
- 30. Amaral PV, Anselin L. Finite sample properties of Moran’s I test for spatial autocorrelation in tobit models. Pap Reg Sci. 2014; 93.
- 31. Anselin L. Local Indicators of Spatial Association—Lisa. Geogr Anal. 1995; 27:93–115.
- 32.
ESRI. Modeling spatial relationships.
- 33. Anselin L, Syabri I, Kho Y. GeoDa: An introduction to spatial data analysis. Geogr Anal. 2006; 38:5–22.
- 34. Kapwata T, Manda S. Geographic assessment of access to health care in patients with cardiovascular disease in South Africa. BMC Health Serv Res. 2018; 18:197. pmid:29566692
- 35. Chirenda J, Gwitira I, Warren RM, Sampson SL, Murwira A, Masimirembwa C, et al. Spatial distribution of Mycobacterium Tuberculosis in metropolitan Harare, Zimbabwe. PLoS One. 2020; 15:e0231637. pmid:32315335
- 36. Kirby RS, Delmelle E, Eberth JM. Advances in spatial epidemiology and geographic information systems. Ann Epidemiol. 2017; 27:1–9. pmid:28081893
- 37. Eniu AE, Martei YM, Trimble EL, Shulman LN. Cancer Care and Control as a Human Right: Recognizing Global Oncology as an Academic Field. Am Soc Clin Oncol Educ Book. 2017; 37:409–15. pmid:28561681
- 38. Ginsburg O, Bray F, Coleman MP, Vanderpuye V, Eniu A, Kotha SR, et al. The global burden of women’s cancers: a grand challenge in global health. Lancet. 2017; 389:847–60. pmid:27814965
- 39. Penchansky R, Thomas JW. The concept of access: definition and relationship to consumer satisfaction. Med Care. 1981; 19:127–40. pmid:7206846
- 40. Bhatia RK, Rayne S, Rate W, Bakwenabatsile L, Monare B, Anakwenze C, et al. Patient Factors Associated With Delays in Obtaining Cancer Care in Botswana. J Glob Oncol. 2018; 4:1–13. pmid:30199305
- 41. Tapela NM, Peluso MJ, Kohler RE, Setlhako II, Botebele K, Gabegwe K, et al. A Step Toward Timely Referral and Early Diagnosis of Cancer: Implementation and Impact on Knowledge of a Primary Care-Based Training Program in Botswana. Front Oncol. 2018; 8:187. pmid:29896450
- 42. Stewart TS, Moodley J, Walter FM. Population risk factors for late-stage presentation of cervical cancer in sub-Saharan Africa. Cancer Epidemiol. 2018; 53:81–92. pmid:29414636
- 43. Barchi F, Winter SC, Ketshogile FM, Ramogola-Masire D. Adherence to screening appointments in a cervical cancer clinic serving HIV-positive women in Botswana. BMC Public Health. 2019; 19:318. pmid:30885175
- 44. Iyer HS, Kohler RE, Ramogola-Masire D, Brown C, Molebatsi K, Grover S, et al. Explaining disparities in oncology health systems delays and stage at diagnosis between men and women in Botswana: A cohort study. PLoS One. 2019; 14:e0218094. pmid:31170274
- 45. Friebel-Klingner TM, Luckett R, Bazzett-Matabele L, Ralefala TB, Monare B, Nassali MN, et al. Clinical and sociodemographic factors associated with late stage cervical cancer diagnosis in Botswana. BMC Womens Health. 2021;21(1):267. pmid:34229672